2025 Q1 Form 10-Q Financial Statement
#000147793225000225 Filed on January 14, 2025
Income Statement
Concept | 2025 Q1 | 2024 Q3 | 2024 Q2 |
---|---|---|---|
Revenue | $20.06K | ||
YoY Change | 1019.48% | ||
Cost Of Revenue | $0.00 | ||
YoY Change | |||
Gross Profit | $20.06K | ||
YoY Change | 1019.48% | ||
Gross Profit Margin | 100.0% | ||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $98.35K | ||
YoY Change | 139.2% | ||
Operating Profit | -$78.28K | ||
YoY Change | 99.08% | ||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | ||
YoY Change | |||
Pretax Income | |||
YoY Change | |||
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$78.45K | ||
YoY Change | 99.51% | ||
Net Earnings / Revenue | -391.07% | ||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.00 | ||
COMMON SHARES | |||
Basic Shares Outstanding | 2.096B shares | 2.096B shares | 2.096B shares |
Diluted Shares Outstanding | 2.096B shares |
Balance Sheet
Concept | 2025 Q1 | 2024 Q3 | 2024 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $307.3K | $25.94K | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | $4.405M | $3.962M | |
Prepaid Expenses | |||
Receivables | $0.00 | $0.00 | |
Other Receivables | |||
Total Short-Term Assets | $4.712M | $3.988M | |
YoY Change | 4253.9% | 3973.03% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.712M | $3.988M | |
Total Long-Term Assets | $0.00 | $0.00 | |
Total Assets | $4.712M | $3.988M | |
YoY Change | 4222.67% | 3939.41% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $4.303M | $3.692M | |
YoY Change | 184.41% | 115.8% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $5.228M | $5.036M | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.303M | $3.692M | |
Total Long-Term Liabilities | $5.228M | $5.036M | |
Total Liabilities | $9.531M | $8.728M | |
YoY Change | 528.81% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$1.378M | -$1.300M | |
YoY Change | -51.45% | -53.6% | |
Common Stock | $209.6K | $209.6K | |
YoY Change | -0.01% | -0.01% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | |||
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.712M | $3.988M | |
YoY Change | 4222.67% | 3939.41% |
Cashflow Statement
Concept | 2025 Q1 | 2024 Q3 | 2024 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$78.45K | ||
YoY Change | 99.51% | ||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | $89.26K | ||
YoY Change | -146.29% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | ||
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $192.1K | ||
YoY Change | -456.69% | ||
NET CHANGE | |||
Cash From Operating Activities | $89.26K | ||
Cash From Investing Activities | $0.00 | ||
Cash From Financing Activities | $192.1K | ||
Net Change In Cash | $281.3K | ||
YoY Change | 25828.48% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | $89.26K | ||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001683252 | |
CY2024Q3 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q3 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2024Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2025 | |
CY2024Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2095671162 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2095671162 | shares |
CY2024Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2095671162 | shares |
CY2024Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | |
CY2024Q3 | dei |
Entity File Number
EntityFileNumber
|
000-55688 | |
CY2024Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
Token Communities Ltd. | |
CY2024Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2024Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
81-3709511 | |
CY2024Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
850 Tidewater Shore Loop | |
CY2024Q3 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 402 | |
CY2024Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Bradenton | |
CY2024Q3 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2024Q3 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
34208 | |
CY2024Q3 | dei |
City Area Code
CityAreaCode
|
631 | |
CY2024Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
397-1111 | |
CY2024Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2025Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2095872947 | shares |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
307263 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
25939 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
0 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
0 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
4404918 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
3961964 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
4712181 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
3987903 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
4712181 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
3987903 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
133573 | usd |
CY2024Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
126573 | usd |
CY2024Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
352156 | usd |
CY2024Q2 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
352156 | usd |
CY2024Q3 | tkcm |
Unearned Revenue Current
UnearnedRevenueCurrent
|
552 | usd |
CY2024Q2 | tkcm |
Unearned Revenue Current
UnearnedRevenueCurrent
|
552 | usd |
CY2024Q3 | tkcm |
Due To Related Party Current
DueToRelatedPartyCurrent
|
3816662 | usd |
CY2024Q2 | tkcm |
Due To Related Party Current
DueToRelatedPartyCurrent
|
3213162 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4302943 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3692443 | usd |
CY2024Q3 | us-gaap |
Construction Loan Noncurrent
ConstructionLoanNoncurrent
|
228022 | usd |
CY2024Q2 | us-gaap |
Construction Loan Noncurrent
ConstructionLoanNoncurrent
|
35960 | usd |
CY2024Q3 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
5000000 | usd |
CY2024Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
5000000 | usd |
CY2024Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
5228022 | usd |
CY2024Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
5035960 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
9530965 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
8728403 | usd |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2095671162 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
209567 | usd |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
209567 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
-3640360 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
-3640360 | usd |
CY2024Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
0 | usd |
CY2024Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
0 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1378430 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1299977 | usd |
CY2024Q3 | us-gaap |
Minority Interest
MinorityInterest
|
-9561 | usd |
CY2024Q2 | us-gaap |
Minority Interest
MinorityInterest
|
-9730 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-4818784 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-4740500 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4712181 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3987903 | usd |
CY2024Q3 | tkcm |
Gross Margin On Home Sales
GrossMarginOnHomeSales
|
0 | usd |
CY2023Q3 | tkcm |
Gross Margin On Home Sales
GrossMarginOnHomeSales
|
0 | usd |
CY2024Q3 | tkcm |
Gross Margin On Lot Sales And Other
GrossMarginOnLotSalesAndOther
|
20061 | usd |
CY2024Q3 | tkcm |
Rent Expenses
RentExpenses
|
0 | usd |
CY2023Q3 | tkcm |
Rent Expenses
RentExpenses
|
0 | usd |
CY2024Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-78284 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-39323 | usd |
CY2024Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
169 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-78453 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37389 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2095671162 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2095671162 | shares |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1386948 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
3772 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-39323 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1422499 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-4740500 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-78284 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-4818784 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-78284 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-39323 | usd |
CY2024Q3 | tkcm |
Other Equity Adjustments
OtherEquityAdjustments
|
0 | usd |
CY2023Q3 | tkcm |
Other Equity Adjustments
OtherEquityAdjustments
|
0 | usd |
CY2024Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2023Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
442954 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
0 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
7000 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
4735 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
603500 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
31913 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
89262 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2675 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2024Q3 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
192062 | usd |
CY2023Q3 | us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | usd |
CY2024Q3 | tkcm |
Repayments Of Acquisition Of Asc Global Inc
RepaymentsOfAcquisitionOfAscGlobalInc
|
0 | usd |
CY2023Q3 | tkcm |
Repayments Of Acquisition Of Asc Global Inc
RepaymentsOfAcquisitionOfAscGlobalInc
|
0 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
192062 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2024Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2023Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3772 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
281324 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1097 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
25939 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1130 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
307263 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2227 | usd |
CY2018Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
19266000 | shares |
CY2018Q1 | tkcm |
Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
|
1 | pure |
CY2018Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
172800000 | shares |
CY2024Q3 | tkcm |
Number Of Shares Outstanding Prior To Merger
NumberOfSharesOutstandingPriorToMerger
|
116466000 | shares |
CY2024Q3 | tkcm |
Surrender Stockholder Shares
SurrenderStockholderShares
|
19266000 | shares |
CY2024Q3 | us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
57107 | usd |
CY2020Q3 | tkcm |
Stock Cancelled During Period Shares Acquisitions
StockCancelledDuringPeriodSharesAcquisitions
|
174540600 | shares |
CY2023Q1 | tkcm |
Promissory Notes Issued To Stockholder
PromissoryNotesIssuedToStockholder
|
225000 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
4818784 | usd |
CY2024Q3 | us-gaap |
Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
|
0.0000 | pure |
CY2023Q3 | us-gaap |
Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
|
1.2199 | pure |
CY2024Q3 | us-gaap |
Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
|
0.0000 | pure |
CY2023Q3 | us-gaap |
Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
|
0.1374 | pure |
CY2024Q3 | tkcm |
Gains And Losses On Extinguishment Of Debt
GainsAndLossesOnExtinguishmentOfDebt
|
730820 | usd |
CY2024Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> | |
CY2024Q3 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended September 30, 2023, the Company identified an immaterial error related to the exclusion of cash balances that impacted the Company’s previously issued June 30, 2023, consolidated financial statements. Management evaluated the effect of the error on the June 30, 2023, financial statements and concluded the error was not material. As a result, in the three months ended September 30, 2023, the Company recorded an out of period adjustment to increase cash, increase related party debt and increase accumulated deficit.</p> | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2095671162 | shares |
CY2024Q3 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive ri | |
CY2024Q2 | tkcm |
Promissory Notes Issued To Stockholder
PromissoryNotesIssuedToStockholder
|
5000000 | usd |
CY2024Q3 | tkcm |
Non Review Textblock
NonReviewTextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 9 – NON REVIEW</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the “Form 10-Q”), was prepared without the consent of its independent accountant, Beckles & Co. Inc. (“Beckles & Co.”) in respect of unaudited interim financial information as of and for the three period ended September 30, 2024 set forth herein, as required by Statement on Auditing Standards No. 100, Interim Financial Statements (the “SAS 100 Review”). Due to the fact that Beckles & Co.s’ SAS 100 Review has not yet been done, the consolidated balance sheets, condensed financial statements as of and for the three month period ended September 30, 2024 included in the Form 10-Q should not be relied upon. The Company intends to file an amended Form 10-Q upon completion of Beckles & Co. s’ SAS 100 Review.</p> | |
CY2024Q3 | tkcm |
Revenue From Home Sales
RevenueFromHomeSales
|
0 | usd |
CY2023Q3 | tkcm |
Revenue From Home Sales
RevenueFromHomeSales
|
0 | usd |
CY2024Q3 | tkcm |
Revenue From Lot Sales And Other
RevenueFromLotSalesAndOther
|
20061 | usd |
CY2023Q3 | tkcm |
Revenue From Lot Sales And Other
RevenueFromLotSalesAndOther
|
1792 | usd |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
20061 | usd |
CY2023Q3 | tkcm |
Gross Margin On Lot Sales And Other
GrossMarginOnLotSalesAndOther
|
1792 | usd |
CY2024Q3 | tkcm |
Cost Of Home Sales
CostOfHomeSales
|
0 | usd |
CY2023Q3 | tkcm |
Cost Of Home Sales
CostOfHomeSales
|
0 | usd |
CY2024Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | usd |
CY2023Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | usd |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
1792 | usd |
CY2024Q3 | us-gaap |
Gross Profit
GrossProfit
|
20061 | usd |
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
1792 | usd |
CY2024Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
0 | usd |
CY2023Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
11578 | usd |
CY2024Q3 | us-gaap |
Legal Fees
LegalFees
|
30500 | usd |
CY2023Q3 | us-gaap |
Legal Fees
LegalFees
|
18594 | usd |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
67845 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10943 | usd |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
98345 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
41115 | usd |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-78284 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-39323 | usd |
CY2024Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2023Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
CY2024Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2023Q3 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-1934 | usd |
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
0 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
3772 | usd |
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-78453 | usd |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-33617 | usd |
CY2024Q3 | tkcm |
Related Party Transaction Due To Related Parties
RelatedPartyTransactionDueToRelatedParties
|
3816662 | usd |
CY2024Q2 | tkcm |
Related Party Transaction Due To Related Parties
RelatedPartyTransactionDueToRelatedParties
|
3213162 | usd |
CY2024Q3 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.04 | pure |
CY2024Q3 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2027-05-10 | |
CY2024Q3 | us-gaap |
Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
|
78333 | usd |